HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.

Abstract
Induction of matrix metalloproteinase (MMP)-9 is particularly important for the invasiveness of breast cancers. We investigated the inhibitory effect of kalopanaxsaponin A (KPS-A) on cell invasion and MMP-9 activation in phorbol 12-myristate 13-acetate (PMA)-treated MCF-7 human breast cancer cells. KPS-A inhibited PMA-induced cell proliferation and invasion. PMA-induced cell invasion was blocked in the presence of a primary antibody of MMP-9, and KPS-A suppressed the increased expression and/or secretion of MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1. Using specific inhibitors, we confirmed that PMA-induced cell invasion and MMP-9 expression is primarily regulated by nuclear factor-kappa B (NF-kappaB) activation via phosphatidylinositol 3-kinase (PI3K)/Akt and activator protein-1 (AP-1) activation via extracellular signal-regulated kinase (ERK)1/2. KPS-A decreased PMA-induced transcriptional activation of NF-kappaB and AP-1 and inhibited PMA-induced phosphorylation of ERK1/2 and Akt. Treatment with the protein kinase C (PKC)delta inhibitor rottlerin caused a marked decrease in PMA-induced MMP-9 secretion and cell invasion, as well as ERK/AP-1 activation, and KPS-A reduced PMA-induced membrane localization of PKCdelta. Furthermore, oral administration of KPS-A led to a substantial decrease in tumor volume and expression of proliferating cell nuclear antigen, MMP-9, TIMP-1 and PKCdelta in mice with MCF-7 breast cancer xenografts in the presence of 17beta-estradiol. These results suggest that KPS-A inhibits PMA-induced invasion by reducing MMP-9 activation, mainly via the PI3K/Akt/NF-kappaB and PKCdelta/ERK/AP-1 pathways in MCF-7 cells and blocks tumor growth and MMP-9-mediated invasiveness in mice with breast carcinoma. Therefore, KPS-A may be a promising anti-invasive agent with the advantage of oral dosing.
AuthorsSun Kyu Park, Young Sun Hwang, Kwang-Kyun Park, Hee-Juhn Park, Jeong Yeon Seo, Won-Yoon Chung
JournalCarcinogenesis (Carcinogenesis) Vol. 30 Issue 7 Pg. 1225-33 (Jul 2009) ISSN: 1460-2180 [Electronic] England
PMID19420016 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Acetophenones
  • Antineoplastic Agents, Phytogenic
  • Benzopyrans
  • NF-kappa B
  • Phosphoinositide-3 Kinase Inhibitors
  • Saponins
  • Transcription Factor AP-1
  • kalopanax saponin A
  • Oleanolic Acid
  • rottlerin
  • Proto-Oncogene Proteins c-akt
  • Protein Kinase C-delta
  • Extracellular Signal-Regulated MAP Kinases
  • Matrix Metalloproteinase 9
  • Tetradecanoylphorbol Acetate
Topics
  • Acetophenones (pharmacology)
  • Animals
  • Antineoplastic Agents, Phytogenic (pharmacology, therapeutic use)
  • Benzopyrans (pharmacology)
  • Breast Neoplasms (chemically induced, pathology, prevention & control)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Extracellular Signal-Regulated MAP Kinases (metabolism)
  • Female
  • Humans
  • Matrix Metalloproteinase 9 (metabolism)
  • Mice
  • Mice, Inbred BALB C
  • NF-kappa B (antagonists & inhibitors, metabolism)
  • Neoplasm Invasiveness
  • Neoplasm Transplantation
  • Oleanolic Acid (analogs & derivatives, pharmacology, therapeutic use)
  • Phosphatidylinositol 3-Kinases (physiology)
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Kinase C-delta (antagonists & inhibitors, metabolism)
  • Proto-Oncogene Proteins c-akt (physiology)
  • Saponins (pharmacology, therapeutic use)
  • Signal Transduction
  • Tetradecanoylphorbol Acetate
  • Transcription Factor AP-1 (metabolism)
  • Transplantation, Heterologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: